Author

P. Guermonprez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

C.-A. Dutertre· 2 shared F. Ginhoux· 2 shared J. Helft· 2 shared P. Bourdely· 2 shared Y. Missolo-Koussou· 2 shared A. Bardelli· 1 shared A. Nicolas· 1 shared A. Saxena· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C.-A. Dutertre

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

DCs targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors

L. Lopez, L. G. Morosi, F. La Terza, P. Bourdely, G. Rospo, R. Amadio, G. M. Piperno, V. Russo, C. Volponi, S. Vodret, S. Joshi, F. Giannese, D. Lazarevic, G. Germano, P. Stoitzner, , F. Benvenuti

The paper shows that DC-based therapy enhances CD8 T cell responses to neoantigens in lung tumors, particularly in high TMB tumors.

bioRxiv · Jan 26, 2024 · PreprintImmunology

Tissue-resident FOLR2+ macrophages associate with tumor-infiltrating CD8+ T cells and with increased survival of breast cancer patients.

R. N. Ramos, Y. Missolo-Koussou, Y. Gerber-Ferder, C. Bromley, M. Bugatti, N. G. Nunez, J. Boari Tosello, W. Richer, J. Denizeau, C. Sedlik, P. Caudana, F. Kotsias, L. L. Niborski, S. Viel, M. Bohec, , J. Helft

The paper identifies FOLR2+ macrophages in breast cancer that correlate with improved patient survival and co-localize with CD8+ T cells across multiple cancers.

bioRxiv · Apr 12, 2021 · PreprintImmunology

Engineered niches support the development of human dendritic cells in humanized mice

G. Anselmi, K. Vaivode, C.-A. Dutertre, P. Bourdely, Y. Missolo-Koussou, E. Newell, O. Hickman, K. Wood, A. Saxena, J. Helft, F. Ginhoux, P. Guermonprez

This study shows engineered mesenchymal stromal cells can generate human dendritic cells in vivo, closely resembling blood-derived cDCs.

bioRxiv · Nov 8, 2019Immunology